Tag: cancer vaccines

Researchers at the 2026 International Conference on Advanced Biomedical Sciences in Taiwan presented advancements in cancer vaccines, T-cell therapies, and ...

A new review synthesizes how tissue-resident memory T cells act as frontline immune sentinels in tumors and could guide biomarker ...

A new review describes how tumor-derived exosomes suppress immunity while immune-cell-derived vesicles boost antitumor responses, highlighting exosome-based vaccines and biomarkers.

A review in the Journal of Ovarian Research surveys clinical trial evidence on CAR-T, TCR-T, TIL and NK cell therapies, ...

Dana-Farber will present the phase 3 DeLLphi-305 primary analysis in extensive-stage small cell lung cancer at the 2026 ESMO Presidential ...

Australian researchers have completed the first head-to-head comparison of three mRNA-lipid nanoparticle vaccine platforms in human blood, revealing key differences ...

A new study in Cancer Discovery shows that circulating tumor DNA and immune cells drawn from a simple blood sample ...

A new review in Molecular Biology Reports surveys how plant, microbial and animal-derived adjuvants could supercharge cancer immunotherapy by activating ...

Researchers have built a whole-body computational model that simulates how vaccination site, timing, and tumor-derived suppression shape anti-cancer immune responses, ...

A new review in Materials Today Bio proposes a bottleneck-first framework for evaluating antigen delivery platforms in therapeutic cancer vaccines, ...

A sweeping new review maps how the epithelial guardian protein MUC1, and especially its MUC1-C signaling subunit, is hijacked by ...

In the relentless battle against cancer, T cells have emerged as pivotal warriors within the adaptive immune system. These specialized ...